Removal of metabolic liabilities enables development of derivatives of procaspase-activating compound 1 (PAC-1) with improved pharmacokinetics

Howard S. Roth, Rachel C. Botham, Steven C. Schmid, Timothy M. Fan, Levent Dirikolu, Paul J. Hergenrother

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Removal of metabolic liabilities enables development of derivatives of procaspase-activating compound 1 (PAC-1) with improved pharmacokinetics'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science